Metabolic Bone Disease in Children with Idiopathic Nephrotic Syndrome

被引:0
|
作者
Boraey, Naglaa F. [1 ]
Addosooki, Ahmad [2 ]
Mohammad, Mohammad A. [2 ]
El-Sonbaty, Marwa M. [3 ]
El-Toukhy, Safinaz E. [4 ,5 ]
机构
[1] Sohag Univ, Fac Med, Dept Pediat, Sohag, Egypt
[2] Sohag Univ, Fac Med, Sohag, Egypt
[3] Natl Res Ctr, Dept Child Hlth, Cairo, Egypt
[4] King Abdulaziz Univ, Fac Sci Girls, Jeddah, Saudi Arabia
[5] Natl Res Ctr, Dept Med Biochem, Cairo, Egypt
关键词
Metabolic bone disease; Nephrotic syndrome; Bone mineral density; Osteoporosis; GLUCOCORTICOID-INDUCED OSTEOPOROSIS; MINERAL DENSITY; LONG-TERM;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Children with idiopathic nephrotic syndrome (INS) may be at risk for metabolic bone disease (MBD) because of biochemical derangements caused by the renal disease, as well as the corticosteroid effects on bone. We studied 70 children with INS for clinical, biochemical, and radiological evidence of MBD. These patients were divided into two groups: 55 frequent relapsers (FR; group I), and 15 infrequent relapsers (IFR; group II). Thirty healthy children matched for age and sex constituted the control group. Bone mineral density (BMD) of these children was evaluated by the Achilles Express Quantitative Ultrasound (QUS) device. Univariate and multivariate analyses were performed to analyze factors predictive of low BMD T- score. We observed that nephrotic children had significantly lower mean BMD T- scores compared with controls (-1.99 +/- 0.74 versus -0.39 +/- 0.87; P = <0.0001). Also, children in group I were found to have significantly lower mean BMD T- scores compared with group II (-2.1 +/- 0.67 versus -1.31 +/- 0.64; P = <0.0001). We also observed that 32.7% of group I had osteoporosis compared to none of group II (P= 0.01). Significantly higher doses of steroids over longer duration of therapy were administered to group I compared with group II (P = < 0.0001 and 0.0004 respectively). On multivariate analysis, the only factor found to be predictive of a low BMD T- score was greater cumulative steroid dose (P= 0.02). We concluded that children with INS are at risk for MBD, especially those receiving higher doses of steroids. Regular BMD evaluation and appropriate therapeutic interventions are recommended for these children. The role of prophylactic therapy in such patients needs to be further investigated. [Naglaa F. Boraey, Ahmad Addosooki, Mohammad A. Mohammad; Marwa M. El-Sonbaty, Safinaz E. El-Toukhy. Metabolic Bone Disease in Children with Idiopathic Nephrotic Syndrome. Life Sci J 2012;9(4):275-280]. (ISSN:1097-8135). http://www.lifesciencesite.com. 40
引用
收藏
页码:275 / 280
页数:6
相关论文
共 50 条
  • [41] IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN: OUR EXPERIENCE
    Zulic, Snezana
    Atic, Nedima
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1927 - 1927
  • [42] CYCLOSPORINE IN THE THERAPY OF IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN
    NIAUDET, P
    BROYER, M
    INTERNATIONAL YEARBOOK OF NEPHROLOGY, 1989, : 155 - 168
  • [43] COMPLEMENT LEVELS IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME
    POLZ, E
    LUBEC, G
    PADIATRIE UND PADOLOGIE, 1977, 12 (04): : 360 - 364
  • [44] THE STUDY ON RELAPSE OF IDIOPATHIC NEPHROTIC SYNDROME IN CHILDREN
    SAKAI, K
    ASAMI, T
    TOMIZAWA, S
    PEDIATRIC RESEARCH, 1980, 14 (08) : 1000 - 1000
  • [45] Cyclosporine A treatment in children with idiopathic nephrotic syndrome
    Kara, O. D.
    Yavascan, O.
    Anil, M.
    Sen, S.
    Aksu, N.
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1644 - 1644
  • [46] Cyclosporine Utilization in Idiopathic Nephrotic Syndrome in Children
    Saeed, Bassam
    Ossman, Mohd Imad
    Sheriff, Shaaban
    SAUDI JOURNAL OF KIDNEY DISEASES AND TRANSPLANTATION, 2006, 17 (04) : 497 - 502
  • [47] The Role of Cytokines and Chemokines as Biomarkers of Disease Activity in Idiopathic Nephrotic Syndrome in Children
    Kopac, Matjaz
    Jerin, Ales
    Petrera, Agnese
    Osredkar, Josko
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2025, 47 (02)
  • [48] Acute renal insufficiency in children with idiopathic nephrotic syndrome
    Vyas, S
    Hidalgo, G
    Baqi, N
    Singh, A
    PEDIATRIC RESEARCH, 1999, 45 (04) : 338A - 338A
  • [49] Idiopathic nephrotic syndrome in children: From corticosteroids to rituximab
    Deschenes, G.
    ARCHIVES DE PEDIATRIE, 2011, 18 (08): : 843 - 845
  • [50] USE OF IMMUNOSUPPRESSIVE THERAPY IN CHILDREN WITH IDIOPATHIC NEPHROTIC SYNDROME
    COCHAT, P
    DAVID, L
    PARCHOUX, B
    FREYCON, MT
    LARBRE, F
    PEDIATRIE, 1987, 42 (07): : 519 - 526